tiprankstipranks
Sonoma Pharmaceuticals, Inc. (SNOA)
:SNOA
US Market

Sonoma Pharmaceuticals (SNOA) Income Statement

Compare
284 Followers

Sonoma Pharmaceuticals Income Statement

Last quarter (Q3 2025), Sonoma Pharmaceuticals's total revenue was $3.56M, an increase of 30.50% from the same quarter last year. In Q3, Sonoma Pharmaceuticals's net income was $-928.00K. See Sonoma Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 12.73M$ 13.27M$ 12.63M$ 18.63M$ 18.94M
Gross Profit
$ 4.75M$ 4.48M$ 3.99M$ 6.56M$ 8.33M
Operating Expenses
$ 9.45M$ 9.05M$ 9.88M$ 10.01M$ 15.00M
Depreciation and Amortization
$ 176.00K$ 298.00K$ 409.00K$ 227.00K$ 312.00K
EBITDA
$ -4.53M$ -4.45M$ -5.70M$ -3.22M$ -3.22M
Operating Income
$ -4.70M$ -4.57M$ -5.89M$ -3.45M$ -6.67M
Other Income/Expenses
$ -330.00K$ -614.00K$ 469.00K$ -453.00K$ 3.85M
Pretax Income
$ -5.03M$ -5.18M$ -5.42M$ -3.90M$ -2.83M
Net Income
$ -4.83M$ -5.15M$ -5.09M$ -4.62M$ -2.95M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -5.32$ -30.40$ -38.40$ -46.20$ -39.80
Diluted EPS
$ -5.32$ -30.40$ -38.40$ -46.20$ -39.80
Weighted Average Shares Outstanding
909.00K 169.70K 132.65K 99.80K 73.85K
Weighted Average Shares Outstanding (Diluted)
909.00K 169.70K 132.65K 99.80K 73.85K
Currency in USD

Sonoma Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis